EP3294278
APOMORPHINE FOR THE TREATMENT OF METHYLPHENIDATE INDUCED HYPERACTIVITY
:
EP einkaleyfi: Þýðing ekki lögð inn:
11.5.2016:
11.5.2022:
16792259.0
:
10.5.2036
:
APOMORPHINE FOR THE TREATMENT OF METHYLPHENIDATE INDUCED HYPERACTIVITY
11.5.2016
11.5.2022
:
4P-Pharma:
Campus de l'Institut Pasteur de Lille 1, rue du Professeur Calmette, 59000 Lille, FR
:
SELA, Yoram:
43263 Raanana, IL
:
LAMENSDORF, Itschak:
71710 Modiin, IL
:
201562160627 P:
13.5.2015:
US
:
IB2016000688:
11.5.2016
:
A61K 31/473, A61K 31/13, A61K 31/485, C07D 221/02, C07D 489/00, A61K 9/00, A61K 45/06, A61K 9/50, A61P 25/00, A61K 9/48, A61K 9/16, A61K 9/28, A61K 31/137, A61K 31/165, A61K 31/445, A61K 31/4458, A61K 31/4468, A61K 31/4535, A61K 31/454, A61K 36/74